의료기기용 나노테크놀러지 시장 - 규모, 점유율, 동향 분석 보고서 : 유형별, 용도별, 최종 용도별, 지역별, 부문 예측(2024-2030년)

Market Size & Trends

The global nanotechnology in medical devices market size was estimated at USD 3.3 billion in 2023 and is projected to grow at a CAGR of 6.8 from 2024 to 2030. This growth is propelled by several pivotal factors. Nanotechnology facilitates the creation of highly precise and targeted medical treatments. Engineered at the nanoscale, materials can interact with biological systems at the molecular level, enabling exact drug delivery and improving therapeutic outcomes significantly.

This precision is particularly critical in addressing intricate diseases such as cancer, where targeted delivery minimizes systemic side effects, enhances treatment efficacy, and potentially improves patient outcomes. As nanotechnology continues to evolve, its applications promise to revolutionize the landscape of medical treatment by providing tailored therapies that offer greater effectiveness and reduced adverse effects, marking a transformative shift in healthcare delivery and patient care standards.

Nanomaterials like quantum dots and nanosensors offer high-resolution imaging of biological structures and processes, providing detailed and precise visualization. This enhanced imaging capability is crucial for the early detection of diseases, allowing for timely and accurate diagnosis. Similarly, it facilitates personalized treatment planning by providing comprehensive insights into individual patient conditions. As a result, the use of nanotechnology in diagnostics contributes to better patient outcomes, as early detection and personalized treatment plans lead to more effective interventions and improved overall healthcare management.

Moreover, nanotechnology promotes the development of smart medical devices that can actively monitor physiological parameters and deliver therapies in real-time. Nanosensors embedded in devices can detect biomarkers indicative of disease progression or treatment response, allowing for timely intervention and personalized medicine approaches. In January 2022, Pfizer Inc. and Acuitas Therapeutics, a company specializing in lipid nanoparticle delivery systems for mRNA-based therapeutics, announced a Development and Option agreement. This agreement grants Pfizer the non-exclusive option to license Acuitas' LNP technology for therapeutic development.

Furthermore, the scalability and cost-effectiveness of nanotechnology are driving its adoption in medical device manufacturing. Advances in nanofabrication techniques have lowered production costs while improving device performance and reliability. This scalability makes nanotechnology accessible to a broader range of healthcare providers and patients, fostering market expansion.

Global Nanotechnology In Medical Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global nanotechnology in medical devices market report based on the type, application, end use, and region:

• Type Outlook (Revenue, USD Million, 2018 - 2030)
• Implantable Devices

Orthopedic Implants

Hearing Aids

Cardiac Rhythm Management Devices

Others

• Dental Filling Materials
• Wound Care
• Others
• Application Outlook (Revenue, USD Million, 2018 - 2030)
• Dentistry
• Orthopedics
• Hearing Loss
• Wound Care
• Others
• End Use Outlook (Revenue, USD Million,2018 - 2030)
• Hospitals
• Clinics
• Others
• Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America

U.S.

Canada

Mexico

• Europe

UK

Germany

France

Italy

Spain

Norway

Denmark

Sweden

• Asia Pacific

Japan

China

India

Australia

South Korea

Thailand

• Latin America

Brazil

Argentina Mexico

• Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Application
  • 1.2.3. End use
  • 1.2.4. Regional Scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Application outlook
  • 2.2.3. End use outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Nanotechnology in Medical Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Nanotechnology in Medical Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Nanotechnology in Medical Devices Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Nanotechnology in Medical Devices Market: Type Movement Analysis
• 4.3. Nanotechnology in Medical Devices Market by Type Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Implantable devices
  • 4.5.1. Implantable Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.2. Orthopedic Implants
    • 4.5.2.1. Orthopedic Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.3. Hearing Aids
    • 4.5.3.1. Hearing Aids Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.4. Cardiac Rhythm Management Devices
    • 4.5.4.1. Orthopedic Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.5. Others
    • 4.5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Dental Filling Materials
  • 4.6.1. Dental Filling Materials Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Wound Care
  • 4.7.1. Wound Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.8. Others
  • 4.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Nanotechnology in Medical Devices Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Nanotechnology in Medical Devices Market: Application Movement Analysis
• 5.3. Nanotechnology in Medical Devices Market by Application Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Dentistry
  • 5.5.1. Dentistry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Orthopedics
  • 5.6.1. Orthopedics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Hearing Loss
  • 5.7.1. Hearing Loss Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. Wound Care
  • 5.8.1. Wound Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.9. Others
  • 5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Nanotechnology in Medical Devices Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Nanotechnology in Medical Devices Market: End Use Movement Analysis
• 6.3. Nanotechnology in Medical Devices Market by End Use Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Hospitals
  • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Clinics
  • 6.6.1. Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Nanotechnology in Medical Devices Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Regional Nanotechnology in Medical Devices Market Movement Analysis
• 7.3. Nanotechnology in Medical Devices Market: Regional Estimates & Trend Analysis by Type, Application & End-use
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. North America
  • 7.5.1. North America Nanotechnology in Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. U.S. Nanotechnology in Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Canada Nanotechnology in Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Mexico Nanotechnology in Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Europe
  • 7.5.6. Europe Nanotechnology in Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. UK
    • 7.5.7.1. UK Nanotechnology in Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Germany
    • 7.5.8.1. Germany Nanotechnology in Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. France
    • 7.5.9.1. France Nanotechnology in Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.10. Italy
    • 7.5.10.1. Italy Nanotechnology in Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.11. Spain
    • 7.5.11.1. Spain Nanotechnology in Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.12. Denmark
    • 7.5.12.1. Denmark Nanotechnology in Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.13. Norway
    • 7.5.13.1. Norway Nanotechnology in Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.14. Sweden
    • 7.5.14.1. Sweden Nanotechnology in Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Nanotechnology in Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Japan Nanotechnology in Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. China Nanotechnology in Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. India Nanotechnology in Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. South Korea Nanotechnology in Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. Australia
    • 7.6.6.1. Australia Nanotechnology in Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Thailand Nanotechnology in Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Nanotechnology in Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Brazil Nanotechnology in Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Argentina Nanotechnology in Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. Middle East & Africa
  • 7.8.1. Middle East & Africa Nanotechnology in Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. South Africa Nanotechnology in Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Saudi Arabia Nanotechnology in Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. UAE Nanotechnology in Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Kuwait Nanotechnology in Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. Smith & Nephew PLC
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. Cochlear Ltd
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Boston Scientific Corporation
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Dentsply Sirona
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Starkey
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Stryker
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. Zimmer Biomet
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. 3M
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Abbott Laboratories
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. LivaNova PLC
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives